Streetbeat News

Stock Prices

DLTR

Over the past 20 years, Dollar Tree (NASDAQ:DLTR) has outperformed the market by 5.65% on an annualized basis, producing an average annual return of 13.66%. If an investor had bought $1000 of DLTR stock 20 years ago, it would be worth $12,623.08 today.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 2:00 pm

KR

Over the past 20 years, Kroger (NYSE:KR) has outperformed the market by 1.07% on an annualized basis, producing an average annual return of 9.08%. If an investor had bought $1000 of KR stock 20 years ago, it would be worth $5,714.79 today.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 2:00 pm

NOV

Over the last quarter, NOV (NYSE:NOV) has received a mix of analyst ratings, with 4 bullish, 4 somewhat bullish, 2 indifferent, and 1 bearish. The company's average 12-month price target is $23.09, which has increased by 3.4% over the past month.

Portfolio Pulse from Benzinga Insights

July 31, 2023 | 2:00 pm

INVZ

LAZR

Citron Research has agreed with Motley Fool's statement that a certain AI company, which is not named in the tweet, is the best AI company that is not widely known. INVZ and LAZR are hinted to be mentioned in the article linked in the tweet.

Portfolio Pulse from Happy Mohamed

July 31, 2023 | 2:00 pm

SYM

Symbotic Inc. (NASDAQ:SYM) reported better-than-expected Q3 revenues of $311.83 million, beating the consensus of $261.02 million. Sales rose 77.6% Y/Y. The company also reported a net loss of $(39.08) million, compared to $(32.88) million net loss a year ago. Symbotic expects Q4 revenue of $290 million-$310 million. The company's shares are trading higher by 9.66%.

Portfolio Pulse from Nabaparna Bhattacharya

July 31, 2023 | 1:57 pm

YELL

Shares of Yellow Corp (YELL) were halted on a circuit breaker due to a sharp increase in the stock price. The stock is now up by 75.4%.

Portfolio Pulse from Happy Mohamed

July 31, 2023 | 1:56 pm

CTXR

The FDA has issued a Complete Response Letter to Citius Pharmaceuticals Inc's (NASDAQ:CTXR) Biologics License Application for denileukin diftitox (Lymphir), requiring enhanced product testing and additional controls. The FDA had no concerns about the safety and efficacy data submitted. In 2021, Citius acquired an exclusive license to develop and commercialize Lymphir in all markets except Japan and certain parts of Asia. CTXR shares are down 16% at $0.94.

Portfolio Pulse from Vandana Singh

July 31, 2023 | 1:55 pm

DKNG

DraftKings (DKNG) stock is down by 4% amid rumors of a 4 million share block trade.

Portfolio Pulse from Happy Mohamed

July 31, 2023 | 1:55 pm

AAPL

AMD

AMZN

BTCUSD

GOOGL

PLTR

QQQ

SPY

TSLA

The upcoming week is expected to be busy with earnings reports from AAPL, AMZN, and AMD, along with Non Farm Payroll Data. The author anticipates potential moves in BTC, SPY, and QQQ. The author also discusses the potential impact of earnings reports on AAPL, AMZN, and AMD, and the potential price movements of TSLA, GOOGL, and PLTR.

Portfolio Pulse from Mando Trading

July 31, 2023 | 1:53 pm

MYMD

Trading of shares for MyMD Pharmaceuticals has resumed.

Portfolio Pulse from Happy Mohamed

July 31, 2023 | 1:50 pm